Data is not available at this time.
Diwang Industrial Holdings Limited operates as a specialized chemical producer, focusing on the research, development, and manufacturing of coating agents and synthetic resins. Its core revenue model is derived from the sale of these products, which include colourants, finishes, and additives, to a diverse industrial client base. The company serves multiple end-markets, including apparel, footwear, handbags, automotive interiors, home furnishings, and sports equipment, leveraging its technical expertise to provide essential materials for surface treatment and decoration. Operating primarily from its base in Hangzhou, China, Diwang has expanded its geographic footprint to include manufacturing and sales operations in Mexico, Turkey, and Vietnam, positioning itself to serve global supply chains and mitigate regional market risks. This international presence allows it to cater to multinational brands and manufacturers seeking reliable, localized suppliers of performance chemicals. The company operates in the competitive specialty chemicals sector, where differentiation is achieved through product innovation, quality consistency, and deep customer relationships rather than scale alone. Its market position is that of a niche player, competing on technical service and the ability to develop customized solutions for specific application requirements across its targeted industries.
For the fiscal year, the company reported revenue of HKD 566.5 million. It achieved a net income of HKD 30.0 million, indicating a net profit margin of approximately 5.3%. Operating cash flow was strong at HKD 59.0 million, significantly exceeding net income and suggesting healthy cash conversion from its operations.
The company generated diluted earnings per share of HKD 0.0417. Capital expenditures were substantial at HKD -93.1 million, indicating significant investment in maintaining or expanding its production capacity. This high level of investment relative to its earnings highlights a capital-intensive business model focused on long-term operational capabilities.
The balance sheet shows a cash position of HKD 54.7 million against total debt of HKD 65.0 million, indicating a moderate but manageable leverage position. The net debt position is minimal, providing some financial flexibility. The company's liquidity appears adequate for its operational needs given its positive cash flow generation.
The company has not instituted a dividend policy, as evidenced by a dividend per share of HKD 0.00, opting instead to reinvest its cash flows back into the business. The significant capital expenditure suggests a strategy focused on capacity expansion or operational upgrades to drive future growth rather than returning capital to shareholders in the near term.
With a market capitalization of approximately HKD 154.8 million, the stock trades at a price-to-earnings ratio of roughly 5.2 based on the reported EPS. This valuation, coupled with a beta of 0.974, suggests the market prices the stock with moderate risk expectations, potentially viewing it as a value opportunity within its sector.
The company's strategic advantages lie in its specialized product portfolio and its growing international manufacturing footprint, which provides resilience and access to key markets. The outlook will depend on its ability to successfully integrate its capital investments, manage input cost inflation, and navigate competitive pressures in the global specialty chemicals landscape.
Company Annual ReportHong Kong Stock Exchange Filings
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |